Immunitybio is trading $8.82 (+4.44%) amid retail speculation following Patrick Soon-Shiong’s discussion of Nant’s planned blockchain and tokenized-stock platform, though no confirmed company-specific announcement dated September 22, 2026 explains the move.
- Executive Chairman Patrick Soon-Shiong discussed the platform on September 20; the report does not explicitly link it to today’s gain.
- Stocktwits sentiment turned bullish with high message volume, but no trading-volume figure was provided.